NewLake Capital Partners (NLCP) Stock Price, News & Analysis

Company Overview

NewLake Capital Partners, Inc. is a real estate investment trust focused on owning and managing properties used by state-licensed cannabis operators in the United States. The company provides real estate capital to cannabis businesses by acquiring cultivation, processing, and retail facilities and leasing those properties to established operators.

NewLake generally uses long-term, triple-net lease arrangements, under which tenants are responsible for most property-level expenses, including taxes, insurance, and maintenance. Its portfolio may support a range of cannabis-related activities, including the cultivation, manufacturing, processing, and sale of medical and adult-use cannabis products, depending on applicable state regulations.

Founded in 2019, NewLake Capital Partners serves cannabis operators across multiple U.S. markets where commercial cannabis activity is permitted. The company is led by a management team with experience in real estate, finance, and the cannabis industry, and its shares trade over the counter under the symbol NLCP.

Key Stats

• Today's Range: $13.60 to $13.89
• 50-Day Range: $13.75 to $16.10
• 52-Week Range: $12.09 to $16.75
• Volume: 38,090 shs
• Average Volume: 86,842 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $15.75
• Consensus Rating: Moderate Buy

Company Calendar

• Last Earnings: 5/12/2022
• Today: 10/13/2026
• LD Micro 20th Annual Main Event Conference: 10/21/2026
• Next Earnings (Estimated): 11/04/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Real Estate
• Industry: Specialized REITs
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:NLCP
• CIK: 1854964
• Web: www.newlake.com
• Phone: 203-594-1402
• Fax: N/A
• Employees: 7
• Year Founded: N/A

Price Target and Rating

• Average Price Target for NewLake Capital Partners: $15.75
• High Price Target: $16.00
• Low Price Target: $15.00
• Potential Upside/Downside: +13.9%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A